A study on human BrMs and glioma sequencing data revealed that type I interferon signaling and nuclear factor-κB (NF-κB) signaling are upregulated in BrMs, and contrastingly not in the microglial cells of gliomas. Here, NFKB1 is linked to central nervous system cancer.